HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
2022 Rome Action Plan on Paediatric HIV & TB
Lupin
Lupin commits to:
388. Finalize the development of 3-medicine paediatric fixed-dose combination product for treatment of drug-sensitive TB, with an aim of submitting a dossier to WHO PQ and ERP by December 2022.
389. Finalize the development of rifapentine 150mg dispersible tablet for TB preventative treatment with an aim of submitting a dossier to WHO PQ and ERP by May 2023.
390. Finalize the development of a clofazimine 50mg tablet for treatment of drug-resistant TB with an aim of submitting a dossier to WHO PQ and ERP by end of 2023.
391. Finalize development of bedaquiline 20mg dispersible tablet for treatment of drug-resistant TB with an aim of submitting a dossier to WHO PQ and ERP by end of 2024.
-